Copyright Reports & Markets. All rights reserved.

Global Preimplantation Genetics Diagnosis (PGD) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Preimplantation Genetics Diagnosis (PGD) Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Gender Selection
    • 1.4.3 Chromosomal Abnormalities
    • 1.4.4 Single Gene Disorders
    • 1.4.5 HLA Typing
    • 1.4.6 Aneuploidy
    • 1.4.7 X-Linked Diseases
    • 1.4.8 Other
  • 1.5 Market by Application
    • 1.5.1 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Perspective (2015-2026)
  • 2.2 Global Preimplantation Genetics Diagnosis (PGD) Growth Trends by Regions
    • 2.2.1 Preimplantation Genetics Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preimplantation Genetics Diagnosis (PGD) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Preimplantation Genetics Diagnosis (PGD) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Preimplantation Genetics Diagnosis (PGD) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Market Size
    • 3.1.1 Global Top Preimplantation Genetics Diagnosis (PGD) Players by Revenue (2015-2020)
    • 3.1.2 Global Preimplantation Genetics Diagnosis (PGD) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Preimplantation Genetics Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio
    • 3.2.1 Global Preimplantation Genetics Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Preimplantation Genetics Diagnosis (PGD) Revenue in 2019
  • 3.3 Preimplantation Genetics Diagnosis (PGD) Key Players Head office and Area Served
  • 3.4 Key Players Preimplantation Genetics Diagnosis (PGD) Product Solution and Service
  • 3.5 Date of Enter into Preimplantation Genetics Diagnosis (PGD) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Preimplantation Genetics Diagnosis (PGD) Historic Market Size by Type (2015-2020)
  • 4.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)
  • 5.2 Global Preimplantation Genetics Diagnosis (PGD) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 6.2 Preimplantation Genetics Diagnosis (PGD) Key Players in North America (2019-2020)
  • 6.3 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 6.4 North America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 7.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Europe (2019-2020)
  • 7.3 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 7.4 Europe Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

8 China

  • 8.1 China Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 8.2 Preimplantation Genetics Diagnosis (PGD) Key Players in China (2019-2020)
  • 8.3 China Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 8.4 China Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 9.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Japan (2019-2020)
  • 9.3 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 9.4 Japan Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 10.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

11 India

  • 11.1 India Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 11.2 Preimplantation Genetics Diagnosis (PGD) Key Players in India (2019-2020)
  • 11.3 India Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 11.4 India Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size (2015-2020)
  • 12.2 Preimplantation Genetics Diagnosis (PGD) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size by Type (2015-2020)
  • 12.4 Central & South America Preimplantation Genetics Diagnosis (PGD) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Abbott Laboratories Company Details
    • 13.1.2 Abbott Laboratories Business Overview
    • 13.1.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.1.4 Abbott Laboratories Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020))
    • 13.1.5 Abbott Laboratories Recent Development
  • 13.2 Natera, Inc
    • 13.2.1 Natera, Inc Company Details
    • 13.2.2 Natera, Inc Business Overview
    • 13.2.3 Natera, Inc Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.2.4 Natera, Inc Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.2.5 Natera, Inc Recent Development
  • 13.3 PerkinElmer
    • 13.3.1 PerkinElmer Company Details
    • 13.3.2 PerkinElmer Business Overview
    • 13.3.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.3.4 PerkinElmer Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.3.5 PerkinElmer Recent Development
  • 13.4 Illumina
    • 13.4.1 Illumina Company Details
    • 13.4.2 Illumina Business Overview
    • 13.4.3 Illumina Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.4.4 Illumina Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.4.5 Illumina Recent Development
  • 13.5 F. Hoffmann-La Roche
    • 13.5.1 F. Hoffmann-La Roche Company Details
    • 13.5.2 F. Hoffmann-La Roche Business Overview
    • 13.5.3 F. Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.5.4 F. Hoffmann-La Roche Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.5.5 F. Hoffmann-La Roche Recent Development
  • 13.6 Thermo Fisher Scientific
    • 13.6.1 Thermo Fisher Scientific Company Details
    • 13.6.2 Thermo Fisher Scientific Business Overview
    • 13.6.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.6.4 Thermo Fisher Scientific Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.6.5 Thermo Fisher Scientific Recent Development
  • 13.7 Laboratory Corporation of America Holdings
    • 13.7.1 Laboratory Corporation of America Holdings Company Details
    • 13.7.2 Laboratory Corporation of America Holdings Business Overview
    • 13.7.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.7.4 Laboratory Corporation of America Holdings Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.7.5 Laboratory Corporation of America Holdings Recent Development
  • 13.8 Agilent Technologies
    • 13.8.1 Agilent Technologies Company Details
    • 13.8.2 Agilent Technologies Business Overview
    • 13.8.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.8.4 Agilent Technologies Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.8.5 Agilent Technologies Recent Development
  • 13.9 Quest Diagnostics Incorporated
    • 13.9.1 Quest Diagnostics Incorporated Company Details
    • 13.9.2 Quest Diagnostics Incorporated Business Overview
    • 13.9.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.9.4 Quest Diagnostics Incorporated Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.9.5 Quest Diagnostics Incorporated Recent Development
  • 13.10 Cooper Surgical
    • 13.10.1 Cooper Surgical Company Details
    • 13.10.2 Cooper Surgical Business Overview
    • 13.10.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Introduction
    • 13.10.4 Cooper Surgical Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 13.10.5 Cooper Surgical Recent Development
  • 13.11 Beijing Genomics Institute (BGI)
    • 10.11.1 Beijing Genomics Institute (BGI) Company Details
    • 10.11.2 Beijing Genomics Institute (BGI) Business Overview
    • 10.11.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Introduction
    • 10.11.4 Beijing Genomics Institute (BGI) Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 10.11.5 Beijing Genomics Institute (BGI) Recent Development
  • 13.12 Genea Limited
    • 10.12.1 Genea Limited Company Details
    • 10.12.2 Genea Limited Business Overview
    • 10.12.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Introduction
    • 10.12.4 Genea Limited Revenue in Preimplantation Genetics Diagnosis (PGD) Business (2015-2020)
    • 10.12.5 Genea Limited Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Preimplantation Genetics Diagnosis (PGD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Abbott Laboratories
    Natera, Inc
    PerkinElmer
    Illumina
    F. Hoffmann-La Roche
    Thermo Fisher Scientific
    Laboratory Corporation of America Holdings
    Agilent Technologies
    Quest Diagnostics Incorporated
    Cooper Surgical
    Beijing Genomics Institute (BGI)
    Genea Limited

    Market segment by Type, the product can be split into
    Gender Selection
    Chromosomal Abnormalities
    Single Gene Disorders
    HLA Typing
    Aneuploidy
    X-Linked Diseases
    Other
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now